Eton Pharmaceuticals Inc is a specialty pharmaceutical company that focuses on developing and commercializing innovative formulations for both existing and new drug products
The company aims to address unmet medical needs by enhancing the delivery and efficacy of medications, primarily in the areas of hospital and specialty pharmacy settings. Eton works on reformulating established drugs to improve their administration, safety, and effectiveness, while also looking to expand access to high-quality treatments for patients and healthcare providers. By leveraging its expertise in drug formulation and development, Eton is committed to bringing new therapeutic options to market that can significantly benefit patient care.
ETON stock results show that Eton Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
ETON stock results show that Eton Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Gainers Amyris, Inc. (NASDAQAMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy.